A clinician can check additional markers to confirm how your body uses B12
It has FDA Angiogenesis Peptides Require Strict Cycling Angiogenesis peptides (BPC-157, TB-500) stimulate new blood vessel growth powerful for tissue repair but potentially harmful if used continuously 5-Amino-1MQ Fat Metabolism Peptide 5-Amino-1MQ inhibits NNMT (nicotinamide N-methyltransferase), an enzyme involved in fat cell metabolism
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
Treatment The injection is quick, and most people feel little to no pain
It matters because a small molecule behaves differently from a peptide in dosing, stability, and how it is studied